Connection

Sergio Raposeiras-Roubín to Purinergic P2Y Receptor Antagonists

This is a "connection" page, showing publications Sergio Raposeiras-Roubín has written about Purinergic P2Y Receptor Antagonists.
  1. Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention. 2018 03 20; 13(16):1914-1922.
    View in: PubMed
    Score: 0.155
  2. Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2018 Jul; 71(7):538-544.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.